Mental Confusion (Delirium): Causes, Symptoms, and Dangers

What is Mental Confusion?

Mental confusion, also known as delirium, is a clinical syndrome characterized by acute alterations of mental status and consciousness, with a reduction or loss of the ability to maintain attention. It develops rapidly, fluctuates throughout the day, and is potentially reversible if correctly identified and treated.

Delirium is almost invariably caused by a documented organic condition, such as:

• Toxic states,
• Head trauma,
• Brain tumors,
• Systemic, metabolic, or infectious diseases.

It is a serious clinical condition, particularly common in older adults, but it frequently goes unrecognized and is often mistaken for dementia or depression.

How Common is Delirium?

In the general population, prevalence ranges from 10 to 30%, rising sharply with age. Among adults over 75 years old living in care homes or hospitalized, rates reach 40–60%. A patient may present with confusion on hospital admission or develop it during hospitalization. In such cases, they may become disoriented, unable to state where they are, what time or day it is, or even recall their own name or address.

Clinical Subtypes

Delirium presents in three main forms:

• Hyperactive delirium: the patient is restless, agitated, and at times aggressive. This presentation must be distinguished from schizophrenia and other psychoses during diagnostic evaluation.
• Hypoactive delirium: characterized by drowsiness, apathy, slowed movements and speech, and torpor. This is the most frequently missed subtype, often confused with depression or simple fatigue.
• Mixed delirium: alternating features of both hyperactive and hypoactive forms.

---

Causes and Risk Factors

Pathophysiology

Mental confusion develops as a result of diffuse disruption of cerebral metabolism, particularly affecting key brain structures that regulate attention:

• Reticular formation,
• Frontal cortex,
• Right parietal lobe,
• Thalamus,
• Caudate nucleus.

At the neurochemical level, delirium involves reduced acetylcholine activity, the neurotransmitter most critically linked to attention and arousal, alongside dysregulation of multiple other neurotransmitter systems, including dopamine, noradrenaline, serotonin, glutamate, GABA, phenylalanine, and tryptophan.

Predisposing Risk Factors in the Elderly

The higher frequency of delirium with advancing age reflects several predisposing vulnerabilities:

• Physiological reduction in cerebral metabolic activity with aging,
• Frequent visual and/or hearing impairment,
• Presence of CNS diseases or other serious medical conditions,
• Polypharmacy (multiple concurrent medications),
• Pre-existing cognitive impairment,
• Dehydration and/or malnutrition,
• Reduced hepatic and renal drug metabolism.

Precipitating Factors in Hospitalized Patients

Additional triggers can precipitate delirium in vulnerable older patients in hospital or care settings:

• Use of physical restraints,
• Introduction of new medications,
• Urinary catheterization,
• Adverse clinical events (infection, drug side effects, falls, pressure sores, surgical complications),
• Psychological distress, such as fear, pain, depression.

Causes: The DELIRIUMS Mnemonic

The diverse causes of delirium can be conveniently recalled using the acronym D.E.L.I.R.I.U.M.S.:

Other important causes include: carbon monoxide or heavy metal toxicity; drug or alcohol abuse or withdrawal; intracranial tumors; epilepsy; cardiac arrhythmias; severe anemia; sleep deprivation; and post-operative states.

---

Symptoms and Signs

Regardless of the precipitating cause, delirium is characterized by a constellation of symptoms across multiple domains:

Cognitive and Consciousness Disturbances

• Severe alterations in consciousness, particularly reduced awareness of the surrounding environment,
• Disorientation in time and space,
• Attention deficits: inability to focus, maintain, or shift attention,
• Disorganized thinking: incoherent, fragmented, or tangential thoughts,
• Language disturbances: confused, irrelevant, or incoherent speech,
• Memory deficits, particularly short-term memory,
• Slowed responses: delayed answering, prolonged reaction time.

Perceptual Disturbances

• Visual and/or auditory hallucinations: particularly, visual hallucinations are highly characteristic of delirium and help distinguish it from primary psychiatric disorders, where auditory hallucinations predominate.
• Illusions: misinterpretation of real sensory stimuli.

Emotional and Behavioral Disturbances

• Anxiety and angst,
• Irritability and nervousness,
• Agitation (hyperactive form) or apathy and withdrawal (hypoactive form),
• Depression and emotional blunting.

Neurovegetative Symptoms

• Pallor, flushing, or cyanosis,
• Pupil dilation,
• Tachycardia,
• Excessive sweating,
• Nausea and vomiting,
• Elevated body temperature.

Neurological Symptoms

• Tremors,
• Involuntary muscle spasms (asterixis, myoclonus),
• Dysarthria (difficulty articulating words),
• Difficulty performing simple voluntary gestures (apraxia),
• Motor stereotypies,
• Incoordination (ataxia),
• Loss of bladder and bowel sphincter control.

The Fluctuating Pattern and “Sundowning”

A hallmark feature of delirium is its fluctuating course; the patient may alternate between periods of relative lucidity and severe cognitive impairment within the same day or even within hours. Worsening typically occurs in the evening and at night. This phenomenon, known as “sundowning syndrome”, involves increased confusion, agitation, and behavioral disturbance as daylight fades.

Prodromal Symptoms

Delirium onset is typically acute. However, especially in elderly patients, warning symptoms may appear hours to days beforehand. These include:

• Drowsiness and daytime somnolence,
• Angst and restlessness,
• Insomnia,
• Appetite disturbances,
• Behavioral changes such as social withdrawal, impaired interaction, and mood disturbances.

The appearance of these prodromal symptoms should always prompt medical consultation. This could be with the patient’s physician or at the nearest emergency department.

---

Complications and Dangers

Delirium is not just a temporary issue. It involves significant morbidity and mortality risks, especially in hospitalized elderly patients. Complications include:

• Urinary incontinence or retention and intestinal dysfunction.
• Atelectasis: collapse of lung segments because of reduced respiratory effort.
• Pressure sores can develop from immobility.
• Malnutrition, which can result from reduced food and fluid intake.
• Falls and injuries: Agitation and confusion significantly increase the risk of falls.
• Drug toxicity: Confused patients are more vulnerable to adverse drug reactions.
• Death: Delirium is independently associated with higher in-hospital mortality.

Beyond direct complications, delirium significantly prolongs hospital stays and is associated with higher rates of re-hospitalization. Long-term consequences in survivors include accelerated cognitive decline, worsening of pre-existing dementia, and reduced functional independence.

---

Diagnosis

Clinical Assessment

Clinical evaluation must be performed by a physician trained in delirium diagnosis. The DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition) remains the gold standard, requiring four criteria: disturbance of consciousness with reduced ability to focus attention; cognitive change (memory deficit, disorientation, language disturbance) not explained by pre-existing dementia; acute onset and fluctuating course; and evidence that the disturbance is caused by a medical condition.

History Taking

Since the patient may be unable to provide a reliable history, information from family members or caregivers is essential. Key questions include:

• Known medical conditions and current medications,
• Substance or alcohol use/abuse,
• Timeline of symptom onset (hours? days?) and fluctuation pattern,
• Previous similar episodes,
• Sleep quality and recent behavioral changes.

Physical and Neurological Examination

The physician evaluates:

• Vital signs: pulse, blood pressure, respiratory rate, temperature, oxygen saturation,
• Consciousness level and attentional capacity,
• Cognitive and perceptual disturbances not explained by pre-existing dementia,
• Neurological and psychiatric signs,
• Cardiac, pulmonary, and abdominal examination.

Laboratory and Instrumental Investigations

Depending on clinical suspicion, investigations may include:

• Blood tests: complete blood count, hepatic and renal function tests, ESR, blood glucose, serum electrolytes (sodium, potassium, phosphorus, calcium).
• Urinalysis and cultures are used to identify urinary tract infections.
• Toxicological screening, syphilis and HIV testing.
• Arterial blood gas (ABG), ECG, chest X-ray.
• CT scan or MRI: these imaging techniques help detect intracranial pathology, such as hemorrhage, tumors, or stroke.

Standardized Assessment Tools

Several validated instruments aid clinical diagnosis and severity quantification:

• Confusion Assessment Method (CAM) is the most widely used screening tool. It assesses four features: acute onset with fluctuating course, inattention, disorganized thinking, and altered level of consciousness. Sensitivity 94–100%, specificity 90–95%.
• Confusional State Evaluation (CSE) evaluates disorientation, behavioral alterations, inappropriate language, and the presence of hallucinations or illusions.
• Delirium Rating Scale (DRS) quantifies delirium severity.
• Mini Mental State Examination (MMSE): useful for baseline cognitive assessment and monitoring.

Distinguishing Delirium from Psychiatric Disorders

Key differentiating features between delirium and primary psychiatric disorders include:

• Onset pattern: delirium typically has an acute, abrupt onset; psychiatric disorders generally develop more slowly with identifiable prodromal symptoms.
• Visual hallucinations: highly characteristic of delirium and underlying metabolic disturbance or drug effects. While they can occur in psychiatric conditions like schizophrenia, auditory hallucinations predominate in primary psychosis.
• Fluctuation: the waxing-and-waning course within hours or days is characteristic of delirium; psychiatric disorders tend to follow a more sustained pattern.
• Consciousness: in delirium, consciousness is typically impaired; in functional psychiatric disorders, it is usually preserved.

---

Treatment

Immediate Response

Call emergency services or take the patient to the nearest emergency department immediately. While awaiting help, it is recommended to:

• Stay with the patient and reassure them. Remind them where they are and who is with them.
• Use simple words and short sentences.
• Note all current medications.
• Avoid unnecessary questions.
• Avoid attempting to physically restrain the patient unless there is immediate danger.

Environmental and Non-Pharmacological Management

The patient must be managed in an appropriate hospital environment: one that is well-lit, comfortable, and quiet. The medical team should adopt a reassuring demeanor and involve family members where possible.

Key non-pharmacological interventions (recommended as first-line by NICE guidelines):

• Adequate hydration and nutrition: Provide IV or nasogastric/parenteral nutrition if oral intake is insufficient. Ensure adequate protein, electrolyte, and vitamin intake.
• Oxygen therapy: Assess the need and provide it if oxygen saturation is reduced.
• Pain management: Treat any underlying pain, since it is a potent precipitant and perpetuating factor for delirium.
• Bowel and bladder regulation: Prevent and treat retention or incontinence.
• Reality Orientation: Regularly communicate simple information about who the patient is, where they are, and what is happening. Use a calm, reassuring tone.
• Sensory support: ensure hearing aids and glasses are available and in use.
• Sleep hygiene: minimize nighttime disruptions and promote a regular day-night cycle.
• Early mobilization: Encourage sitting up, standing, and supervised walking as soon as it is clinically safe.
• Remove identifiable risk factors: Discontinue unnecessary medications, remove catheters as soon as possible, and minimize restraint use.

Pharmacological Treatment

Pharmacological treatment should be considered only when non-pharmacological measures are insufficient to manage distress, and particularly when perceptual disturbances (hallucinations, illusions) or severe agitation pose a risk to the patient or staff.

Antipsychotics

Antipsychotics are the medications of choice for managing behavioral symptoms of delirium, but must be used at the lowest effective dose and with great caution, as they can worsen confusion if overused. They should be discontinued as soon as the patient stabilizes.

The most commonly used agents are:

Special caution: In patients with Parkinson’s disease or Lewy body dementia, antipsychotics, especially haloperidol and other typical agents, can cause severe and potentially fatal neuroleptic sensitivity reactions. Quetiapine or clozapine are preferred in these populations.

Benzodiazepines

Benzodiazepines (such as lorazepam and oxazepam) are specifically indicated for delirium caused by alcohol or sedative-hypnotic withdrawal. In these cases, antipsychotics alone are not enough. They act rapidly, but their effects are only sedative. They do not modify the underlying course of delirium. They must never be used in the presence of respiratory depression.

Treating the Underlying Cause

The most important therapeutic intervention is identifying and treating the underlying medical condition causing the delirium. Without this, symptomatic management will not produce lasting resolution. This may involve:

• Treating infection with appropriate antibiotics,
• Correcting metabolic imbalances (electrolytes, glucose, hydration),
• Managing cardiac arrhythmias or heart failure,
• Stopping or replacing offending medications,
• Surgical evacuation of intracranial hemorrhage.

---

Sources and Bibliography

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV). APA, 1994.
• Inouye SK, van Dyck CH, Alessi CA, et al. “Clarifying confusion: the confusion assessment method. A new method for detection of delirium”. Annals of Internal Medicine, 1990; 113(12):941–948.
• National Institute for Health and Care Excellence (NICE). Delirium: prevention, diagnosis and management in hospital and long-term care. NICE Clinical Guideline CG103, 2010 (updated 2023).
• Maldonado JR. “Neuropathogenesis of delirium: review of current etiologic theories and common pathways”. American Journal of Geriatric Psychiatry, 2013; 21(12):1190–1222.
• Marcantonio ER. “Delirium in Hospitalized Older Adults”. New England Journal of Medicine, 2017; 377(15):1456–1466.
• American Academy of Family Physicians (AAFP). Delirium: Differential Diagnosis and Management. American Family Physician, 2003; 67(5):1027–1034.
• Siddiqi N et al. “Interventions for preventing delirium in hospitalised non-ICU patients”. Cochrane Database of Systematic Reviews, 2016; (3):CD005563.
• Wilson JE et al. “Delirium”. Nature Reviews Disease Primers, 2020; 6(1):90.